Discure Technologies

Discure is a pioneering company in the MedTech industry, focusing on developing minimally invasive, bioelectronic solutions to treat low back pain and degenerative disc disease. The company serves patients suffering from spinal and synovial joint issues, aiming to provide effective treatments without the need for hospitalization or rehabilitation. Discure operates in the global healthcare market, targeting both Europe and North America, where it is currently running clinical trials. The business model revolves around the development and commercialization of its unique disc regeneration system, which has received FDA Breakthrough Device designation, facilitating faster market access. Revenue is generated through the sale and licensing of its medical devices. Discure has been recognized with multiple awards, including the Orthopedics This Week award for New Technology and has been a finalist in several prestigious MedTech and HealthTech competitions. The company boasts an experienced management team and a panel of renowned scientific and clinical expert advisors, ensuring the highest standards in research and development.

Keywords: bioelectronic, minimally invasive, low back pain, degenerative disc disease, FDA Breakthrough, clinical trials, MedTech, spine treatment, disc regeneration, healthcare innovation.